Stock listing
Exagen Inc.
Selected listing: A2PRXT · LS · EUR · DE
Exagen Inc. (Lang & Schwarz: A2PRXT), Health Services. Latest release Aug 4, 2026: Exagen Inc. Reports Second Quarter 2026 Financial Results.
- Ticker
- Lang & Schwarz: A2PRXT
- Asset type
- Stock
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Exagen Inc.
Exagen Inc. Reports Second Quarter 2026 Financial Results
August 4, 2026
Exagen Inc. to Participate in Upcoming Investor Conference
July 28, 2026
Exagen to Announce Second Quarter Financial Results on August 4, 2026
July 20, 2026
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
May 31, 2026
Exagen Inc. Reports First Quarter 2026 Results
May 11, 2026
Events
Research Exagen Inc.
Alternate listings
XGN:NASDAQ
US · USD
Alternate listing for Exagen Inc.; the primary context on this page is A2PRXT:LS.
XGN:BOATS
US · USD
Alternate listing for Exagen Inc.; the primary context on this page is A2PRXT:LS.
E08A:GETTEX
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is A2PRXT:LS.
A2PRXT:LSX
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is A2PRXT:LS.
E08A:DUS
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is A2PRXT:LS.
E08A:FWB
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is A2PRXT:LS.
E08A:MUN
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is A2PRXT:LS.
E08A:SWB
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is A2PRXT:LS.
E08A:TRADEGATE
DE · EUR
Alternate listing for Exagen Inc.; the primary context on this page is A2PRXT:LS.